share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Greene John

SEC announcement ·  Jun 1 04:21
Summary by Futu AI
In a recent transaction, John Greene, associated with CRISPR Therapeutics (CRSP.US), executed a stock action on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-action shareholding, were not disclosed in the announcement. Investors are advised to monitor CRISPR Therapeutics for any further disclosures that may provide additional insights into the transaction's impact on the company's stock.
In a recent transaction, John Greene, associated with CRISPR Therapeutics (CRSP.US), executed a stock action on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-action shareholding, were not disclosed in the announcement. Investors are advised to monitor CRISPR Therapeutics for any further disclosures that may provide additional insights into the transaction's impact on the company's stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.